|
Rodney W. Unsworth is group vice president and president, Asia-Pacific Region, of Schering-Plough Corporation.
Unsworth has held various senior level international management roles in the pharmaceutical industry with Asia-Pacific and Australian companies. Before joining Schering-Plough, he was actively involved in assisting small medical research-based companies, including ObjectiVision Pty. Ltd. and BioDiem Ltd. in Australia, to commercialize their innovation potential. Prior to this position, he served as regional president, Asia-Pacific Region, for the former Pharmacia Corporation.
He has a degree in pharmacy from the Victorian College of Pharmacy, Australia.
Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. In November 2007, Schering-Plough acquired Organon BioSciences, with its Organon human health and Intervet animal health businesses, marking a pivotal step in the company's ongoing transformation. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its approximately 50,000 people around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com. | 